3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 2a
1
Lymphoma, B-Cell
1
Lethal Congenital Contracture Syndrome 2
1
Gynecological Solid Tumors
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
29
blinatumomab
19
Vincristine
16
Specimen Handling
13
Methotrexate
13
Dexamethasone
13
fludarabine
12
Prednisone
11
Cytarabine
11
Biopsy
11
Doxorubicin
9
Asparaginase
9
Rituximab
8
Mercaptopurine
8
Inotuzumab Ozogamicin
8
merphos
7
Spinal Puncture
7
N,N-dicyclohexyl-isoborneol-10-sulfonamide
7
Magnetic Resonance Spectroscopy
7
venetoclax
6
prednylidene
6
dexamethasone acetate
6
dexamethasone 21-phosphate
6
deltacortene
6
azathiopurine
6
auricularum
6
Etoposide
6
Daunorubicin
6
Calcium Dobesilate
6
pegaspargase
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Burkitt Lymphoma
×
Antibodies, Bispecific
×
Clear all
NCT06796517
2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
72 enrolled